Mutlu Hızal
7PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 22, 2025
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.Mehmet Ali Nahit Sendur, Mutlu Hizal, Burcu Çakar
|May 03, 2023
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.Seda Kahraman, Enes Erul, Mustafa Seyyar
|Sep 01, 2022
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).Mutlu Hizal, Burak Bilgin, Nail Paksoy
|Jun 23, 2022
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.Mutlu Hizal, Burak Bilgin, Nail Paksoy
|Nov 02, 2021
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.Emre Yekedüz, İsmail Ertürk, Deniz Tural
|Jul 31, 2021
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study.Mutlu Hizal, Burak Bilgin, Nail Paksoy
Pageof 2
Frequent Collaborators
2 joint publications
Gokhan Ucar
2 joint publications
Yüksel Ürün
2 joint publications
Seda Kahraman
2 joint publications
Deniz Tural
1 joint publications
Hatime Arzu Yasar
1 joint publications
Dilek Erdem
1 joint publications
Tuğba Akın Telli
1 joint publications
Naziye Ak
1 joint publications
Nadiye Akdeniz
1 joint publications
Enes Erul
